#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erdheim-Chester disease Mantle cell lymphoma recurrent Encephalitis autoimmune Medullary thyroid cancer Ovarian epithelial cancer Oesophageal adenocarcinoma stage II Cystic fibrosis Haemophagocytic lymphohistiocytosis Neuroendocrine carcinoma of the skin Pyruvate kinase deficiency anaemia Rhabdomyosarcoma Osteosarcoma recurrent Gastrointestinal neuroendocrine tumour Prostate cancer Vulval cancer More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Treatment Leukoencephalopathy – Basic Information IgA nephropathy – Trials in Disease Leiomyosarcoma recurrent – Trials in Disease Marfan’s syndrome – Basic Information Soft tissue sarcoma VEXAS syndrome – Diagnostics Hereditary motor and sensory neuropathy – Treatment Malignant fibrous histiocytoma – Treatment Mucopolysaccharidosis III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluticasone Ocrelizumab NALOXEGOL L-Tryptophan Ethanol (96 Per Cent) Jnj-81241459 Sodium Valproate Fasudil Hydrochloride Psma-11 Oxygen Sodium Acetate Trihydrate Meldonium 68Ga-Dpi-4452 Safinamide L-SERINE Ly3819469 Sodium Axicabtagene Ciloleucel Riociguat Specific Nucleic Acid Sna-Veru Cctx-001 More therapies…

    Learn about Your Condition

    Hypoxia Systemic lupus erythematosus Spinal osteoarthritis Dermatitis atopic Follicular thyroid cancer Trisomy 21 Cutaneous lupus erythematosus Neurofibrosarcoma Bacterial prostatitis Persistent depressive disorder Synovial sarcoma recurrent Rhinitis allergic Multifocal motor neuropathy Malignant fibrous histiocytoma Pseudoxanthoma elasticum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital cystic kidney disease

  • Study on Hydrochlorothiazide and Tolvaptan for Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Hydrochlorothiazide
    • Tolvaptan
    Austria Belgium France Germany The Netherlands Spain

  • A study to evaluate the safety and tolerability of azathioprine in patients with autosomal dominant polycystic kidney and liver disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Azathioprine
    Belgium

  • Study of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • ABBV-CLS-628
    Belgium France Germany Italy The Netherlands Portugal +1

  • Study of Empagliflozin for Patients with Autosomal Dominant Polycystic Kidney Disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Empagliflozin
    Germany

  • Study on the Safety and Effects of Tolvaptan for Infants and Young Children with Autosomal Recessive Polycystic Kidney Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Tolvaptan
    Belgium Germany Poland Spain

  • Study on the Effects of Amiloride and Sodium Chloride on Vascular Stiffness in Patients with Polycystic Kidney Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Amiloride
    • Potato Starch
    • Sodium Chloride
    The Netherlands
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!